| Financial Year |
March 31 2023 |
| Monetary Funds |
72,450,733,950.67 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
-- |
| Accounts Receivable |
58,410,415.90 |
| Advances to Suppliers |
94,506,059.17 |
| Other Receivables |
33,117,697.48 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
40,052,820,428.01 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
79,893,276.91 |
| Total Current Assets |
218,200,387,403.57 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
4,573,527.72 |
| Fixed Assetes |
19,489,407,362.20 |
| Under-construction Projects |
2,417,566,489.04 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
8,429,135,452.56 |
| R&D expenses |
216,821,784.65 |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
146,067,537.16 |
| Deferred Income Tax Assets |
3,473,325,563.84 |
| Other Non-Current Assets |
-- |
| Sub-Total of Non-Current Assets |
40,190,395,418.48 |
| Total Assets |
258,390,782,822.05 |
| Short-Term Loans |
-- |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
2,640,205,442.62 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
444,910,939.59 |
| Taxes Payable |
6,862,663,394.19 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
4,217,175,098.28 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
90,213,406.15 |
| Other Current Liabilities |
980,466,527.83 |
| Sub-Total of Current Liabilities |
31,428,606,894.51 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
162,628,090.99 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
498,601,724.91 |
| Total Liabilities |
31,927,208,619.42 |
| Paid-In Capital(Or Share Stock) |
1,256,197,800.00 |
| Capital Surplus |
1,374,964,415.72 |
| Surplus Reserve |
32,520,123,399.97 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
182,072,885,561.65 |
| Minority Stockholder's Interest |
8,187,882,900.01 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
218,275,691,302.62 |
| Owner's Equity（Stockholder's Equity） |
226,463,574,202.63 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
258,390,782,822.05 |
